Skip Nav Destination
.png?versionId=8919)
President's Column
Keep Your Eyes on the Prize
February 14, 2025
"Let’s stay the course as we grow and nurture the best hematology workforce possible, promote first-rate, equitable care, and improve the lives of our patients.”
Technology Spotlight
Mass spectrometry-based antibody characterization has greatly aided in the implication of the anti-PF4 M-protein in the pathogenesis of monoclonal gammopathy of thrombotic significance.
First Relapse, Second Chance
Is there new hope for pediatric patients who relapse with acute lymphoblastic leukemia?
Targeting the Rare
A study evaluates the safety and efficacy of luveltamab tazevibulin in treating a subtype of acute myeloid leukemia bearing the CBFA2T3-GLIS2 gene fusion.
